8-K Announcements
6Material company update
Mar 13, 2026·SEC
Material company update
Jan 27, 2026·SEC
Material company update
Jan 9, 2026·SEC
Savara Inc.(SVRA)Earnings, Financials & Key Ratios
SVRA•NASDAQ
$5.27
$911M mkt cap·Price updated May 6, 2026
AboutSavara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.Show more
- Revenue$0
- EBITDA-$103M-72.0%
- Net Income-$96M-75.3%
- EPS (Diluted)-0.48-45.5%
- ROE-61.5%-39.5%
- ROIC-47.87%-18.1%
- Debt/Equity0.16-17.4%
SVRA Key Insights
Savara Inc. (SVRA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Shares diluted 20.0% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SVRA Price & Volume
Savara Inc. (SVRA) stock price & volume — 10-year historical chart
Loading chart...
SVRA Growth Metrics
Savara Inc. (SVRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-39.44%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-25.73%
Return on Capital
10 Years-46.37%
5 Years-40.31%
3 Years-40.89%
Last Year-56.53%
SVRA Recent Earnings
Savara Inc. (SVRA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)
Q2 2026Latest
Mar 13, 2026EPS
$0.13
Est $0.12
-8.3%
Revenue
—
Q4 2025
Nov 12, 2025EPS
$0.14
Est $0.13
-7.7%
Revenue
—
Q3 2025
Aug 13, 2025EPS
$0.14
Est $0.12
-16.7%
Revenue
—
Q2 2025
May 13, 2025EPS
$0.12
Est $0.12
+0.0%
Revenue
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 13, 2026 | $0.13vs $0.12-8.3% | — |
| Q4 2025 | Nov 12, 2025 | $0.14vs $0.13-7.7% | — |
| Q3 2025 | Aug 13, 2025 | $0.14vs $0.12-16.7% | — |
| Q2 2025 | May 13, 2025 | $0.12vs $0.12+0.0% | — |
Based on last 12 quarters of dataView full earnings history →
SVRA Peer Comparison
Savara Inc. (SVRA) competitors in Commercial Rare Disease Biopharma — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 INSM | 29.14B | 137.09 | -21.35 | 66.73% | -264.83% | -125.2% | 0.06 | |
 TBPH | 858.38M | 16.94 | -14.73 | 12.12% | 36.53% | 14.69% | 0.28 | |
 PRAX | 7.61B | 337.95 | -25.07 | -100% | -58.74% | 0.00 | ||
 MNKD | 1.1B | 3.56 | 178 | 22.23% | -6.63% | |||
 VTRS | 18.37B | 15.95 | -5.32 | -2.98% | -24.58% | -23.89% | 0.98 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 NKTR | 1.67B | 85.09 | -8.75 | -43.89% | -192.87% | -356.81% | 0.95 | |
 PULM | 4.97M | 1.36 | -0.96 | -100% | -135.49% |
Compare SVRA vs Peers
Savara Inc. (SVRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SVRA Income Statement
Savara Inc. (SVRA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 400K | 0 | 0 | 0 | 257K | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 740640.74% | -100% | - | - | - | -100% | - | - | - | - |
| Cost of Goods Sold | 0 | 363K | 526K | 38.78M | 35.04M | 28.99M | 27.88M | 44.26M | 78.03M | 1.36M |
| COGS % of Revenue | - | - | - | - | 13633.46% | - | - | - | - | - |
| Gross Profit | 400K▲ 0% | -363K▼ 190.8% | -526K▼ 44.9% | -38.78M▼ 7272.8% | -34.78M▲ 10.3% | -28.99M▲ 16.6% | -27.88M▲ 3.8% | -44.26M▼ 58.8% | -78.03M▼ 76.3% | -1.36M▲ 0% |
| Gross Margin % | 100% | - | - | - | -13533.46% | - | - | - | - | - |
| Gross Profit Growth % | 374.07% | -190.75% | -44.9% | -7272.81% | 10.31% | 16.65% | 3.84% | -58.76% | -76.29% | - |
| Operating Expenses | 11.35M | 29.96M | 48.35M | 40.24M | 14.52M | 12.49M | 10.96M | 15.74M | 25.17M | 119.94M |
| OpEx % of Revenue | 2837% | - | - | - | 5649.42% | - | - | - | - | - |
| Selling, General & Admin | 2.82M | 11.08M | 10.65M | 12.86M | 11.96M | 12.35M | 10.93M | 15.67M | 25.04M | 37.34M |
| SG&A % of Revenue | 705% | - | - | - | 4655.25% | - | - | - | - | - |
| Research & Development | 8.18M | 18.51M | 37.17M | 38.78M | 35.04M | 28.99M | 27.88M | 44.26M | 78.03M | 83.8M |
| R&D % of Revenue | 2045.5% | - | - | - | 13633.46% | - | - | - | - | - |
| Other Operating Expenses | -43K | 363K | 526K | -11.4M | -32.48M | -28.86M | -27.85M | -44.19M | -77.9M | -1.19M |
| Operating Income | -10.95M▲ 0% | -29.96M▼ 173.6% | -70.05M▼ 133.8% | -79.03M▼ 12.8% | -49.3M▲ 37.6% | -41.48M▲ 15.9% | -38.84M▲ 6.4% | -60.01M▼ 54.5% | -103.2M▼ 72.0% | -121.3M▲ 0% |
| Operating Margin % | -2737% | - | - | - | -19182.88% | - | - | - | - | - |
| Operating Income Growth % | 72.19% | -173.62% | -133.83% | -12.82% | 37.61% | 15.87% | 6.36% | -54.5% | -71.97% | - |
| EBITDA | -10.6M | -29.59M | -69.52M | -78.71M | -49.05M | -41.34M | -38.81M | -59.93M | -103.07M | -121.1M |
| EBITDA Margin % | -2650.5% | - | - | - | -19083.66% | - | - | - | - | - |
| EBITDA Growth % | 72.97% | -179.13% | -134.92% | -13.23% | 37.69% | 15.71% | 6.13% | -54.43% | -71.98% | -35.32% |
| D&A (Non-Cash Add-back) | 346K | 363K | 526K | 311K | 255K | 136K | 31K | 77K | 130K | 208K |
| EBIT | -10.83M | -32.27M | -70.03M | -50.74M | -46.11M | -40.63M | -38.04M | -59.21M | -102.4M | -117.7M |
| Net Interest Income | -452K | 0 | 0 | -70K | -1.48M | -2.28M | -87.91K | 4.44M | 6.47M | 4.88M |
| Interest Income | 122K | 0 | 0 | 0 | 0 | 2.28K | 88 | 4.44M | 6.47M | 4.88M |
| Interest Expense | 468K | 1.16M | 11K | 70K | 1.48M | 2.28M | 88K | 0 | 0 | 0 |
| Other Income/Expense | -332K | -3.48M | 18K | 852K | -315K | -1.54M | 689K | 5.31M | 7.32M | 5.66M |
| Pretax Income | -11.28M▲ 0% | -33.43M▼ 196.4% | -70.03M▼ 109.5% | -78.17M▼ 11.6% | -49.62M▲ 36.5% | -43.01M▲ 13.3% | -38.15M▲ 11.3% | -54.7M▼ 43.4% | -95.88M▼ 75.3% | -115.64M▲ 0% |
| Pretax Margin % | -2820% | - | - | - | -19305.45% | - | - | - | - | - |
| Income Tax | -357K | -3.63M | -8.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 3.16% | 10.87% | 12.15% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -10.92M▲ 0% | -29.8M▼ 172.8% | -61.52M▼ 106.5% | -78.17M▼ 27.1% | -49.62M▲ 36.5% | -43.01M▲ 13.3% | -38.15M▲ 11.3% | -54.7M▼ 43.4% | -95.88M▼ 75.3% | -115.64M▲ 0% |
| Net Margin % | -2730.75% | - | - | - | -19305.45% | - | - | - | - | - |
| Net Income Growth % | 72.58% | -172.79% | -106.45% | -27.08% | 36.53% | 13.3% | 11.31% | -43.38% | -75.29% | -39.44% |
| Net Income (Continuing) | -10.92M | -29.8M | -61.52M | -78.17M | -49.62M | -43.01M | -38.15M | -54.7M | -95.88M | -115.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.27▲ 0% | -1.70▲ 48.0% | -1.85▼ 8.8% | -2.62▼ 41.6% | -0.84▲ 67.9% | -0.32▲ 61.9% | -0.25▲ 21.9% | -0.33▼ 32.0% | -0.48▼ 45.5% | -0.53▲ 0% |
| EPS Growth % | 80.98% | 48.01% | -8.82% | -41.62% | 67.94% | 61.9% | 21.88% | -32% | -45.45% | -25.73% |
| EPS (Basic) | -3.27 | -1.70 | -1.85 | -2.62 | -0.84 | -0.32 | -0.25 | -0.33 | -0.48 | - |
| Diluted Shares Outstanding | 3.35M | 17.52M | 33.3M | 40.03M | 59.31M | 133.92M | 152.77M | 165.2M | 198.19M | 216.46M |
| Basic Shares Outstanding | 3.35M | 17.52M | 33.3M | 40.03M | 59.31M | 133.92M | 152.77M | 165.2M | 198.19M | 216.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
SVRA Balance Sheet
Savara Inc. (SVRA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 14.61M | 97.86M | 113.34M | 124.07M | 85.12M | 165M | 128.95M | 165.95M | 202.13M | 128.2M |
| Cash & Short-Term Investments | 13.37M | 94.31M | 110.83M | 121.76M | 82.19M | 161.17M | 125.88M | 162.32M | 196.33M | 124.39M |
| Cash Only | 13.37M | 22.12M | 24.3M | 49.8M | 22.88M | 34.01M | 52.1M | 26.59M | 15.13M | 16.28M |
| Short-Term Investments | 0 | 72.19M | 86.53M | 71.96M | 59.31M | 127.16M | 73.78M | 135.73M | 181.2M | 108.11M |
| Accounts Receivable | 868K | 1.03M | 1.68M | 1.62M | 1.7M | 1.14M | 954K | 1M | 1.04M | 1.1M |
| Days Sales Outstanding | 792.05 | - | - | - | 2.41K | - | - | - | - | - |
| Inventory | 337K | 2.48M | 0 | -1.62M | 0 | -1.14M | 2.05M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | 2.49K | - | - | - | - | 26.88 | - | - | - |
| Other Current Assets | 94K | 40K | 107K | 1.62M | 0 | 1.5M | -1.98M | 280K | 455K | 532K |
| Total Non-Current Assets | 14.32M | 61.76M | 38.94M | 12.14M | 12.62M | 11.6M | 10.82M | 11.62M | 10.74M | 12.73M |
| Property, Plant & Equipment | 793K | 925K | 522K | 352K | 156K | 73K | 51K | 270K | 165K | 85K |
| Fixed Asset Turnover | 0.50x | - | - | - | 1.65x | - | - | - | - | 0.00x |
| Goodwill | 3.05M | 27.08M | 26.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.48M | 33.63M | 11.37M | 11.11M | 12.22M | 11.27M | 10.66M | 10.96M | 10.34M | 11.65M |
| Long-Term Investments | -1.13M | -465K | -3.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 131K | 131K | 131K | 673K | 250K | 251K | 116K | 387K | 242K | 3.26M |
| Total Assets | 28.93M▲ 0% | 159.63M▲ 451.7% | 152.29M▼ 4.6% | 136.2M▼ 10.6% | 97.75M▼ 28.2% | 176.6M▲ 80.7% | 139.78M▼ 20.9% | 177.56M▲ 27.0% | 212.88M▲ 19.9% | 140.92M▲ 0% |
| Asset Turnover | 0.01x | - | - | - | 0.00x | - | - | - | - | 0.00x |
| Asset Growth % | -46.63% | 451.7% | -4.6% | -10.56% | -28.24% | 80.67% | -20.85% | 27.03% | 19.89% | 15.75% |
| Total Current Liabilities | 3.46M | 6.01M | 7.25M | 10.88M | 8.17M | 14.66M | 5.87M | 10.6M | 14.72M | 16.76M |
| Accounts Payable | 536K | 2.78M | 3.88M | 3.41M | 2.6M | 1.44M | 1.33M | 3.5M | 4.54M | 4.14M |
| Days Payables Outstanding | - | 2.8K | 2.69K | 32.08 | 27.03 | 18.17 | 17.47 | 28.9 | 21.26 | 1.27K |
| Short-Term Debt | 0 | 265K | 41K | 2M | 0 | 8.33M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 2.15M | 2.96M | 250K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 47K | 1.06M | 2.4M | 0 | 1.92M | 0 | 0 | 4.05M | 5.02M | 3.92M |
| Current Ratio | 4.23x | 16.27x | 15.63x | 11.40x | 10.41x | 11.26x | 21.98x | 15.66x | 13.73x | 13.73x |
| Quick Ratio | 4.13x | 15.86x | 15.63x | 11.55x | 10.41x | 11.33x | 21.63x | 15.66x | 13.73x | 13.73x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 61.35M | 34.3M | 36.81M | 23.63M | 25.19M | 17.44M | 26.13M | 26.59M | 26.71M | 29.78M |
| Long-Term Debt | 3.45M | 14.78M | 24.53M | 23.11M | 25.1M | 17.32M | 26.08M | 26.35M | 26.62M | 29.78M |
| Capital Lease Obligations | 579K | 297K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 2.31M | 7.18M | 3.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 55.02M | 12.05M | 12.28M | 513K | 84K | 117K | 54K | 247K | 87K | 131K |
| Total Liabilities | 64.81M | 40.32M | 152.29M | 34.51M | 33.36M | 32.1M | 32M | 37.19M | 41.43M | 46.54M |
| Total Debt | 4.47M | 15.34M | 24.57M | 25.55M | 25.28M | 25.79M | 26.14M | 26.49M | 26.73M | 29.83M |
| Net Debt | -8.9M | -6.78M | 270K | -24.25M | 2.4M | -8.22M | -25.96M | -94K | 11.61M | 13.55M |
| Debt / Equity | - | 0.13x | 0.23x | 0.25x | 0.39x | 0.18x | 0.24x | 0.19x | 0.16x | 0.16x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.25x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.11x |
| Interest Coverage | -23.39x | -25.80x | -6367.73x | -1128.93x | -33.27x | -18.18x | -441.35x | - | - | - |
| Total Equity | -35.88M▲ 0% | 119.31M▲ 432.6% | 108.22M▼ 9.3% | 101.7M▼ 6.0% | 64.38M▼ 36.7% | 144.5M▲ 124.4% | 107.78M▼ 25.4% | 140.37M▲ 30.2% | 171.45M▲ 22.1% | 94.39M▲ 0% |
| Equity Growth % | -250.17% | 432.57% | -9.3% | -6.03% | -36.69% | 124.44% | -25.41% | 30.24% | 22.14% | 9.25% |
| Book Value per Share | -10.72 | 6.81 | 3.25 | 2.54 | 1.09 | 1.08 | 0.71 | 0.85 | 0.87 | 0.44 |
| Total Shareholders' Equity | -35.88M | 119.31M | 108.22M | 101.7M | 64.38M | 144.5M | 107.78M | 140.37M | 171.45M | 94.39M |
| Common Stock | 5K | 32K | 36K | 52K | 55K | 116K | 116K | 140K | 173K | 173K |
| Retained Earnings | -38.41M | -68.2M | -129.72M | -207.89M | -257.51M | -300.52M | -338.67M | -393.37M | -489.25M | -575.85M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -591K | 958K | 200K | -17K | 942K | 5K | -605K | -271K | -750K | -155K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SVRA Cash Flow Statement
Savara Inc. (SVRA) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -8.37M | -28.23M | -39.27M | -45.12M | -39.84M | -40.08M | -34.55M | -51.06M | -89.09M | -89.09M |
| Operating CF Margin % | -2092.5% | - | - | - | -15500.39% | - | - | - | - | - |
| Operating CF Growth % | 74.6% | -237.32% | -39.11% | -14.89% | 11.72% | -0.61% | 13.79% | -47.77% | -74.47% | -97.05% |
| Net Income | -10.92M | -29.8M | -61.52M | -78.17M | -49.62M | -43.01M | -38.15M | -54.7M | -95.88M | -115.64M |
| Depreciation & Amortization | 346K | 363K | 526K | 1.01M | 693K | 367K | 167K | 77K | 130K | 102K |
| Stock-Based Compensation | 209K | 552K | 3.74M | 4.44M | 5.11M | 3.26M | 2.04M | 4.18M | 9.86M | 8.68M |
| Deferred Taxes | -2.41M | -2.82M | -7.06M | 25.98M | -219K | 1.7M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.91M | 5.5M | 22.59M | 774K | 5.9M | 449K | 428K | -4.69M | -5.03M | 704K |
| Working Capital Changes | 1.5M | -2.03M | 2.45M | 847K | -1.71M | -2.85M | 960K | 4.07M | 1.83M | 6.9M |
| Change in Receivables | -7K | -54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.97M | 159K | 1.55M | 568K | -1.14M | -1.76M | -319K | 4.54M | 4.2M | 3.42M |
| Cash from Investing | -8K | -69.11M | -13.62M | 15.74M | 9.05M | -69.46M | 52.65M | -57.12M | -39.94M | 93.02M |
| Capital Expenditures | -8K | -495K | -141K | -148K | -3.29M | -57K | -9K | -296K | -25K | -11K |
| CapEx % of Revenue | 2% | - | - | - | 1281.71% | - | - | - | - | - |
| Acquisitions | 0 | 3.44M | -10.27M | -14.13M | 3.25M | -8.2M | 0 | 56.82K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -15.21M | 3.44M | 10.27M | 14.13M | -3.25M | 8.2M | 0 | -56.82K | 0 | 0 |
| Cash from Financing | 5.12M | 106.09M | 55.19M | 54.91M | 3.69M | 120.81M | 87K | 82.78M | 117.58M | 1.4M |
| Debt Issued (Net) | 4.33M | 14.44M | 8.82M | -41K | -514K | 0 | 88K | 0 | 0 | 2.37M |
| Equity Issued (Net) | 782K | 1000K | 1000K | 1000K | 1000K | 1000K | -3K | 1000K | 1000K | -966K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -78K | -3K | -1.21M | -995K | -1.25M |
| Other Financing | 1K | 389K | 77K | 110K | 1.91M | -1.35M | 2K | 0 | 400K | 0 |
| Net Change in Cash | -3.31M▲ 0% | 8.75M▲ 364.3% | 2.18M▼ 75.1% | 25.5M▲ 1069.9% | -26.92M▼ 205.6% | 11.13M▲ 141.3% | 18.09M▲ 62.5% | -25.52M▼ 241.1% | -11.46M▲ 55.1% | -5.15M▲ 0% |
| Free Cash Flow | -8.38M▲ 0% | -28.73M▼ 242.9% | -39.42M▼ 37.2% | -45.27M▼ 14.9% | -43.13M▲ 4.7% | -40.14M▲ 6.9% | -34.56M▲ 13.9% | -51.36M▼ 48.6% | -89.11M▼ 73.5% | -99.27M▲ 0% |
| FCF Margin % | -2094.5% | - | - | - | -16782.1% | - | - | - | - | - |
| FCF Growth % | 74.7% | -242.91% | -37.2% | -14.85% | 4.73% | 6.94% | 13.89% | -48.59% | -73.52% | -21.85% |
| FCF per Share | -2.50 | -1.64 | -1.18 | -1.13 | -0.73 | -0.30 | -0.23 | -0.31 | -0.45 | -0.45 |
| FCF Conversion (FCF/Net Income) | 0.77x | 0.95x | 0.64x | 0.58x | 0.80x | 0.93x | 0.91x | 0.93x | 0.93x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 1.61M | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SVRA Key Ratios
Savara Inc. (SVRA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -71.43% | -54.07% | -74.48% | -59.75% | -41.19% | -30.24% | -44.08% | -61.5% | -122.52% |
| Return on Invested Capital (ROIC) | - | -66.33% | -47.54% | -63.75% | -51.27% | -30.64% | -26.71% | -40.53% | -47.87% | -47.87% |
| Gross Margin | 100% | - | - | - | -13533.46% | - | - | - | - | - |
| Net Margin | -2730.75% | - | - | - | -19305.45% | - | - | - | - | - |
| Debt / Equity | - | 0.13x | 0.23x | 0.25x | 0.39x | 0.18x | 0.24x | 0.19x | 0.16x | 0.16x |
| Interest Coverage | -23.39x | -25.80x | -6367.73x | -1128.93x | -33.27x | -18.18x | -441.35x | - | - | - |
| FCF Conversion | 0.77x | 0.95x | 0.64x | 0.58x | 0.80x | 0.93x | 0.91x | 0.93x | 0.93x | 0.86x |
| Revenue Growth | 740640.74% | -100% | - | - | - | -100% | - | - | - | - |
SVRA SEC Filings & Documents
Savara Inc. (SVRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
SVRA Frequently Asked Questions
Savara Inc. (SVRA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Savara Inc. (SVRA) grew revenue by 0.0% over the past year. Growth has been modest.
Savara Inc. (SVRA) reported a net loss of $115.6M for fiscal year 2024.
Dividend & Returns
Savara Inc. (SVRA) has a return on equity (ROE) of -61.5%. Negative ROE indicates the company is unprofitable.
Savara Inc. (SVRA) had negative free cash flow of $99.3M in fiscal year 2024, likely due to heavy capital investments.
Explore More SVRA
Savara Inc. (SVRA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates